Frank Priou

4.5k citations
52 papers · 3.3k · 2 hit papers · h-index 24

Impact in

  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Treatment and Pharmacology
    • Cancer Diagnosis and Treatment
    • Prostate Cancer Treatment and Research
    • Prostate Cancer Diagnosis and Treatment
    • Renal cell carcinoma treatment

Papers in

    • Prostate Cancer Treatment and Research 16
    • Renal cell carcinoma treatment 6
    • Prostate Cancer Diagnosis and Treatment 2
    • Cancer Treatment and Pharmacology 4
    • HER2/EGFR in Cancer Research 4

Frank Priou

51 papers receiving 3.2k citations

Frank Priou's Hit Papers

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design 2022 · 546 citations
5460+2+4Years since publication200400600

Peers

Frank Priou
Comparison fields: 5 of 81
  • Oncology 1.4k
  • Pulmonary and Respiratory Medicine 1.5k
  • Cancer Research 465
  • Radiology, Nuclear Medicine and Imaging 352
  • Immunology 209
Replace Francis X. Parnis with:
Francis X. Parnis Australia
Damien Pouessel France
V.A. Miller United States
Pavlos Papakostas Greece
Erminia Manfrin Italy
László Landherr Hungary
Roger Ove United States
Benoit Beuselinck Belgium
Christian Borel France
Carlos Hernández Hernández United States
Frank Priou relative to Francis X. Parnis Australia Francis X. Parnis's profile →
Citations per field
00.5×2×4×6×8×9.6×
Francis X. Parnis · 1×
Citations per year

Countries citing papers authored by Frank Priou

Since Specialization
Citations

This map shows the geographic impact of Frank Priou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Priou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Priou more than expected).

Fields of papers citing papers by Frank Priou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Priou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Priou. The network helps show where Frank Priou may publish in the future.

Co-authors

The 25 scholars most cited alongside Frank Priou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Priou Line = papers co-authored together Frank Priou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Hit paper breakdown →
2020668
2
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Hit paper breakdown →
2022546
3 2019226
4 2015184
5 2019135
6 2020124
7 2003117
8 2011117
9 2007112
10 2019104
11 201082
12 200269
13 201169
14 202369
15 200268
16 201752
17 201146
18 201744
19 200943
20 201239

About Frank Priou

Frank Priou is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Reproductive Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 52 papers that have together received 3.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), Renal cell carcinoma treatment (6 papers), Ovarian cancer diagnosis and treatment (4 papers), Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.5k citations), Cancer Research (465 citations), Radiology, Nuclear Medicine and Imaging (352 citations) and Immunology (209 citations). Frank Priou has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Philippe Beuzeboc, Stéphane Marie. Oudard, Gwénaëlle Gravis, Florence Joly, Stéphane Culine, Bruno P. Coudert, Thierry Lesimple, Yacine Merrouche, Jean‐Pierre Droz and Christine Chevreau. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, The Lancet Oncology and European Urology Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact